Save (0) ClosePlease login to bookmarkPlease loginnOtsuka Pharmaceuticals and Bristol Myers-Squibb are seeking to withdraw admissions in patent litigation against Generic Health over anti-psychotic drug […]
Subscribe for instant access to all Lawyerly content.